SIMILASAN Inflammations gorge glob 15 g

7680509370472 CH-50937 20.01.1.
SIMILASAN Inflammations gorge glob 15 g
SIMILASAN Inflammations gorge glob 15 g
SIMILASAN Inflammations gorge glob 15 g
1 / 3
google

Details

Product number
5093701
CPT
-
Packaging group
15
Unit
g
Composition
apis mellifica D10, belladonna (Ph.Eur.Hom.) D8, hydrargyri diiodidum D12, lachesis (HAB) D12 ana partes, calcii carbonas et xylitolum ad globulos.

Articles (1)

Similasan Halsentzündungen, Globuli
Globuli
15
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/03/2013
Patient information leaflet
Français
08/03/2013
Patient information leaflet
Italien
08/03/2013

Detailed composition

Substance Quantity Type Category
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
2.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
600.0 MG Substance HNIDK

Authorization holder

Similasan AG

8916 Jonen

Authorization information

Swissmedic authorization number
50937
Drug name
Similasan Halsentzündungen, Globuli
Galenic form
GLO
Authorization status
Z
Dispensation category
D
First authorization
14/08/1991
Authorization expiration date
31/12/9999
IT number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild kann Similasan Halsentzündungen, Globuli bei akuten und chronischen, schmerzhaften Halsentzündungen angewendet werden

Packaging details

Description (FR)
SIMILASAN Inflammations gorge glob 15 g
Description (DE)
SIMILASAN Halsentzündungen Glob 15 g
Market launch
14/08/1991
Narcotic (BTM)
No

Other packaging sizes